Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

Hypha Labs (FUNI) Liabilities from Discontinued Operations (2022 - 2023)

Hypha Labs filings provide 2 years of Liabilities from Discontinued Operations readings, the most recent being 150336.0 for Q4 2023.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 150336.0 in Q4 2023 year-over-year; TTM through Dec 2023 was 150336.0, a N/A change, with the full-year FY2023 number at 368655.0, down 22.76% from a year prior.
Liabilities from Discontinued Operations hit 150336.0 in Q4 2023 for Hypha Labs, down from 368655.0 in the prior quarter.
In the past five years, Liabilities from Discontinued Operations ranged from a high of 477274.0 in Q3 2022 to a low of 150336.0 in Q4 2023.